Patents by Inventor Lars Sejergaard

Lars Sejergaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of controlling a polypeptide modification reaction
    Patent number: 10851364
    Abstract: The invention relates to a method of controlling a polypeptide modification reaction, in particular but not exclusively, a method of controlling the activation of human factor VII (FVII) to produce human factor VII(a) (FVII(a)). The invention also relates to polypeptides obtainable by the polypeptide modification reaction and to pharmaceutical compositions comprising said polypeptides.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: December 1, 2020
    Assignee: NOVO NORDISK HEALTHCARE AG
    Inventors: Lars Sejergaard, Janus Krarup
  • Method of Controlling a Polypeptide Modification Reaction
    Publication number: 20180362953
    Abstract: The invention relates to a method of controlling a polypeptide modification reaction, in particular but not exclusively, a method of controlling the activation of human factor VII (FVII) to produce human factor VII(a) (FVII(a)). The invention also relates to polypeptides obtainable by the polypeptide modification reaction and to pharmaceutical compositions comprising said polypeptides.
    Type: Application
    Filed: March 13, 2018
    Publication date: December 20, 2018
    Inventors: Lars Sejergaard, Janus Krarup
  • Method of Controlling a Polypeptide Modification Reaction
    Publication number: 20160130573
    Abstract: The invention relates to a method of controlling a polypeptide modification reaction, in particular but not exclusively, a method of controlling the activation of human factor VII (FVII) to produce human factor VII(a) (FVII(a)). The invention also relates to polypeptides obtainable by the polypeptide modification reaction and to pharmaceutical compositions comprising said polypeptides.
    Type: Application
    Filed: November 6, 2015
    Publication date: May 12, 2016
    Inventors: Lars Sejergaard, Janus Krarup
  • Method of Controlling a Polypeptide Modification Reaction
    Publication number: 20110177580
    Abstract: The invention relates to a method of controlling a polypeptide modification reaction, in particular but not exclusively, a method of controlling the activation of human factor VII (FVII) to produce human factor VII(a) (FVII(a)). The invention also relates to polypeptides obtainable by the polypeptide modification reaction and to pharmaceutical compositions comprising said polypeptides.
    Type: Application
    Filed: May 29, 2009
    Publication date: July 21, 2011
    Applicant: Novo Nordisk HEalthcare AG
    Inventors: Lars Sejergaard, Janus Krarup